Amylyx Pharmaceuticals, Inc.
AMLXNasdaqCIK 1658551HealthcareFiscal year ends Dec 31
Reports and events: 89 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-10-1317:20 ET | 8-K | 8.01 Other events | 0001193125-23-256178 |
| 2023-10-0416:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-250741 |
| 2023-08-1717:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-215139 |
| 2023-08-1016:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041335 |
| 2023-08-1016:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-041274 |
| 2023-07-2616:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-194655 |
| 2023-06-2317:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-173965 |
| 2023-06-0908:14 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-164027 |
| 2023-05-1117:04 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021369 |
| 2023-05-1116:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-021181 |
| 2023-04-2716:06 ET | DEF 14A | Proxy statementPeriod 2023-06-08 | 0000950170-23-015261 |
| 2023-04-0316:43 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-089658 |
| 2023-03-2116:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-075821 |
| 2023-03-1316:54 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-007609 |
| 2023-03-1316:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-007580 |
| 2023-02-1406:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-23-036988 |
| 2022-12-0616:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-299375 |
| 2022-11-1016:12 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024465 |
| 2022-11-1016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-024448 |
| 2022-11-0216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-275812 |
| 2022-10-0416:03 ET | S-1 | Registration statement | 0001193125-22-257577 |
| 2022-09-3016:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-22-255483 |
| 2022-09-3007:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-254838 |
| 2022-08-1117:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-218745 |
| 2022-08-1116:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016883 |
| 2022-08-1116:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016880 |
| 2022-07-0517:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-188015 |
| 2022-06-1307:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-172425 |
| 2022-06-0916:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-171014 |
| 2022-06-0307:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-166699 |
| 2022-05-1216:26 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009695 |
| 2022-05-1216:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-009674 |
| 2022-04-2907:04 ET | DEF 14A | Proxy statementPeriod 2022-06-09 | 0001193125-22-130050 |
| 2022-03-3114:23 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-005157 |
| 2022-03-3120:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-005093 |
| 2022-01-2516:54 ET | SC 13D | Ownership report, active investor | 0001193125-22-017123 |
| 2022-01-1116:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-006731 |
| 2022-01-0306:57 ET | S-1/A | Registration statement, amended | 0001193125-22-000260 |
| 2021-12-1617:29 ET | S-1 | Registration statement | 0001193125-21-359405 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 14:43 ET. Listed shows no prices and gives no investment advice.